Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,36%
1 096,72
+3,98
+0,36%
—1 092,741 095,951 103,321 094,72——
SIXC
Communications
SIXC
Communications
SIXC
-0,33%
611,32
-2,04
-0,33%
—613,36613,36613,36609,50——
SIXE
Energy
SIXE
Energy
SIXE
-0,45%
1 171,54
-5,25
-0,45%
—1 176,791 176,521 182,251 166,69——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,45%
1 747,63
-7,91
-0,45%
—1 755,541 759,231 766,301 746,04——
SIXM
Financials
SIXM
Financials
SIXM
-0,58%
631,49
-3,66
-0,58%
—635,15635,20636,89630,09——
SIXR
Staples
SIXR
Staples
SIXR
+0,23%
849,94
+1,93
+0,23%
—848,01852,52855,78849,58——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,09%
218,06
+0,20
+0,09%
—217,86217,86219,52217,86——
SIXT
Technology
SIXT
Technology
SIXT
+3,47%
3 536,03
+118,68
+3,47%
—3 417,353 452,773 536,033 450,39——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,91%
905,07
-8,29
-0,91%
—913,36915,10920,43904,57——
SIXV
Health care
SIXV
Health care
SIXV
-0,86%
1 449,86
-12,52
-0,86%
—1 462,381 461,131 464,531 446,02——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,30%
2 430,47
+7,33
+0,30%
—2 423,142 428,712 448,692 424,63——
ABVX:EPA
Abivax SA
105,70 €
+0,19%
(+0,20) 1D
11-май, 09:08:38 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABVX...
Open
105,20 €
High
105,80 €
Low
105,00 €
Mkt. cap
8,42 млд
Avg. vol.
125,20 миң
Volume
2,55 миң
52-wk high
132,00 €
52-wk low
5,00 €
EPS
-4,83 €
Shares outstanding
79,69 млн
No. of employees
69
News stories
From sources across the web
Profile
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
About Abivax SA
CEOMarc de Garidel | Hartmut J. Ehrlich
Employees69
Founded2013-ж., 4-дек.
Headquarters-
Sector-
Websiteabivax.com
Last report
2026-ж., 23-мар.
Fiscal Period
Q4 2025
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
1,91 млн / 1,35 млн
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
970,00 миң
1,05 млн
639,00 миң
1,91 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
39,30 млн
38,64 млн
55,42 млн
44,40 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,89 млн
8,94 млн
27,34 млн
27,69 млн
Operating expense
48,17 млн
47,54 млн
81,35 млн
73,56 млн
Total operating expenses
48,17 млн
47,54 млн
81,35 млн
73,56 млн
Operating income
-47,20 млн
-46,50 млн
-80,71 млн
-71,65 млн
Other non operating income
431,00 миң
2,66 млн
-74,20 млн
-4,96 млн
EBT including unusual items
-52,37 млн
-48,41 млн
-153,36 млн
-76,11 млн
EBT excluding unusual items
-51,32 млн
-48,41 млн
-153,36 млн
-80,84 млн
Income tax expense
-
-
-
5,85 млн
Effective tax rate
-
-
-
-7,68%
Other operating expenses
-24,00 миң
-46,00 миң
-1,40 млн
1,47 млн
Net income
-52,37 млн
-48,41 млн
-153,36 млн
-81,96 млн
Net profit margin
-5 398,97%
-4 624,07%
-23 999,69%
-4 282,13%
Earnings per share
-
-
-
-
Interest and investment income
859,00 миң
190,00 миң
3,36 млн
1,19 млн
Interest expense
-4,54 млн
-3,52 млн
-4,21 млн
-15,27 млн
Net interest expenses
-3,68 млн
-3,33 млн
-852,00 миң
-14,08 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-47,12 млн
-46,47 млн
-80,63 млн
-70,76 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer